Amphastar Pharmaceuticals (AMPH) Current Taxes (2013 - 2026)

Amphastar Pharmaceuticals' Current Taxes history runs 14 years deep, the most recent figure standing at $414000.0 for Q1 2026.

• On a quarterly basis, Current Taxes fell 97.27% year-over-year to $414000.0 in Q1 2026; TTM through Mar 2026 was $414000.0, a 97.27% decrease from a year earlier, with the FY2025 full-year figure at $239000.0, down 97.53% from the prior year.
• Current Taxes climbed to $414000.0 in Q1 2026 per AMPH's latest filing, from $239000.0 in the prior quarter.
• Across five years, Current Taxes topped out at $31.1 million in Q3 2023 and bottomed at $239000.0 in Q4 2025.
• The 5-year median for Current Taxes is $4.6 million (2022), against an average of $7.2 million.
• Across the five-year window, Current Taxes surged 2864.15% in 2023 and slumped 97.53% in 2025, its largest moves.
• Year by year, Current Taxes stood at $4.6 million in 2022, then sank by 64.8% to $1.6 million in 2023, then soared by 500.62% to $9.7 million in 2024, then slumped by 97.53% to $239000.0 in 2025, then surged by 73.22% to $414000.0 in 2026.
• Per Business Quant, the three latest AMPH Current Taxes figures stand at $414000.0 (Q1 2026), $239000.0 (Q4 2025), and $5.6 million (Q3 2025).